CONSENSUS REPORT FROM BIO-INTERNATIONAL 89 - ISSUES IN THE EVALUATION OF BIOAVAILABILITY DATA

被引:20
作者
MCGILVERAY, IJ
MIDHA, KK
SKELLY, JP
DIGHE, S
DOLUISIO, JT
FRENCH, IW
KARIM, A
BURFORD, R
机构
[1] UNIV SASKATCHEWAN,COLL PHARM,SASKATOON S7N 0W0,SASKATCHEWAN,CANADA
[2] US FDA,ROCKVILLE,MD 20857
[3] UNIV TEXAS,COLL PHARM,AUSTIN,TX 78712
[4] SEARLE LABS,CHICAGO,IL 60680
[5] TRIMEL CORP,ETOBICOKE,ONTARIO,CANADA
[6] AMER CLIN RES CONSULTANTS,WILTON,CT
关键词
D O I
10.1002/jps.2600791022
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:945 / 946
页数:2
相关论文
共 2 条
[1]  
URSO R, 1973, EUR J CLIN PHARMACOL, V25, P689
[2]  
1989, OCT BIOINT 89 TOR